LIPT1 Gene Leigh Syndrome Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing laboratory. We offer the LIPT1 Gene Leigh Syndrome Genetic Test for individuals suspected of having Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies related to the LIPT1 gene.
Test Details
The LIPT1 gene is associated with Leigh syndrome, a rare genetic disorder characterized by progressive neurological deterioration. Mutations in the LIPT1 gene can lead to deficiencies in pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, enzymes involved in energy production within cells. These deficiencies result in the accumulation of toxic metabolites and impaired energy production in the brain and other tissues.
To diagnose Leigh syndrome due to LIPT1 gene mutations, we offer a Next-Generation Sequencing (NGS) genetic test. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including LIPT1, to identify any disease-causing mutations.
Test Components and Price
- Test Name: LIPT1 Gene Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies LIPT1 related Genetic Test
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA Card as sample conditions for this test.
Report Delivery
You can expect to receive your test results within 3 to 4 weeks after sample submission.
Method
We utilize NGS technology to perform the LIPT1 Gene Leigh Syndrome Genetic Test.
Test Type
This test is specifically designed for the diagnosis of neurological disorders.
Referring Doctor and Test Department
Your referring doctor for this test should be a neurologist. The test will be conducted in our Genetics department.
Pre Test Information
Prior to undergoing the LIPT1 Gene Leigh Syndrome Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by LIPT1 Gene Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies.
Why Choose LIPT1 Gene Leigh Syndrome Genetic Test
Our LIPT1 Gene Leigh Syndrome Genetic Test is a comprehensive and reliable method to diagnose Leigh syndrome due to LIPT1 gene mutations. The results of this test can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of LIPT1 gene mutations in individuals suspected of having Leigh syndrome and guide further management and treatment options.
It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling. They can provide appropriate guidance and support to individuals and families affected by Leigh syndrome due to LIPT1 gene mutations.
At DNA Labs UAE, we are committed to providing accurate and timely genetic testing services. Contact us today to schedule your LIPT1 Gene Leigh Syndrome Genetic Test and take a step towards understanding your genetic health.
| Test Name | LIPT1 Gene Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies LIPT1 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for LIPT1 Gene Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies, LIPT1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LIPT1 Gene Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies, LIPT1 related |
| Test Details |
The LIPT1 gene is associated with Leigh syndrome, which is a rare genetic disorder characterized by progressive neurological deterioration. Leigh syndrome can be caused by mutations in various genes, including LIPT1. In particular, mutations in the LIPT1 gene can lead to deficiencies in pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are enzymes involved in energy production within cells. These deficiencies result in the accumulation of toxic metabolites and impaired energy production in the brain and other tissues. To diagnose Leigh syndrome due to LIPT1 gene mutations, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including LIPT1, to identify any disease-causing mutations. The NGS genetic test involves obtaining a DNA sample from the individual, typically through a blood sample or saliva collection. The DNA is then sequenced using NGS technology, and the data is analyzed to identify any mutations or variants in the LIPT1 gene that may be responsible for the Leigh syndrome phenotype. The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of LIPT1 gene mutations in individuals suspected of having Leigh syndrome and guide further management and treatment options. It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling. They can provide appropriate guidance and support to individuals and families affected by Leigh syndrome due to LIPT1 gene mutations. |
